Study guide

Section 2.14: Pharmaceutical Calculations: Osmolarity, Milliequivalents, and Alligations

Saudi Pharmacist Licensure Examination SPLE - Pharmacist

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

Section 0.1: About the Saudi Pharmacist Licensure Examination (SPLE) Section 0.2: How to Study and Prep for the SPLE

2 Chapter 1: Basic Biomedical Sciences

Section 1.1: Human Physiology & Pathophysiology Foundations Section 1.2: Medical Biochemistry & Enzymology Section 1.3: Medical Microbiology & Immunology Section 1.4: Molecular Genetics & Pharmacogenomics Foundations

3 Chapter 2: Pharmaceutical Sciences

Section 2.1: Medicinal Chemistry & Structure-Activity Relationships (SAR) Section 2.2: Drug ADME (Absorption, Distribution, Metabolism, Excretion) Section 2.3: General Pharmacology: Mechanisms of Drug Action Section 2.4: General Toxicology: Overdose, Antidotes & Adverse Drug Reactions (ADRs) Section 2.5: Pharmacognosy: Natural Products & Dietary Supplements Section 2.6: Basic Pharmaceutics & Dosage Form Design Section 2.7: Biopharmaceutics & Drug Delivery Systems Section 2.8: Applied Pharmacokinetics (PK): One-Compartment Models Section 2.9: Non-linear and Multi-compartment Pharmacokinetics Section 2.10: Sterile Compounding: Techniques & Quality Standards Section 2.11: Non-sterile Compounding & Product Formulation Section 2.12: Pharmaceutical Calculations: Dosing and Strengths Section 2.13: Pharmaceutical Calculations: Dilutions and Reconstitution Section 2.14: Pharmaceutical Calculations: Osmolarity, Milliequivalents, and Alligations

4 Chapter 3: Social, Behavioral, and Administrative Sciences

Section 3.1: Saudi Arabian Healthcare System & Public Health Policies Section 3.2: Pharmacoepidemiology & Post-Marketing Drug Surveillance Section 3.3: Pharmacovigilance & Drug Safety Monitoring in Saudi Arabia Section 3.4: Pharmacoeconomic Principles & Cost-Benefit Analysis Section 3.5: Pharmacy Management, Inventory, and Operations Section 3.6: Saudi Pharmacy Law & SFDA Regulations Section 3.7: Biostatistics, Clinical Trial Design & Literature Evaluation Section 3.8: Professional Ethics, Communication, and Dispensing Systems

5 Chapter 4: Clinical Sciences

Section 4.1: Drug Information Services & Evidence-Based Medicine Section 4.2: Clinical Pharmacokinetics & Therapeutic Drug Monitoring (TDM) Section 4.3: Clinical Pharmacogenomics & Personalized Therapeutics Section 4.4: Disease Prevention, Wellness, and Immunization Schedules Section 4.5: Patient Assessment & Physical Examination Interpretation Section 4.6: Clinical Pharmacology: Cardiovascular Disorders Section 4.7: Clinical Pharmacology: Renal & Urological Disorders Section 4.8: Clinical Pharmacology: Respiratory & Pulmonary Disorders Section 4.9: Clinical Pharmacology: Endocrine & Metabolic Disorders Section 4.10: Clinical Pharmacology: Infectious Diseases & Antimicrobial Stewardship Section 4.11: Clinical Pharmacology: Neurological & Psychiatric Disorders Section 4.12: Clinical Pharmacology: Oncology, Immunology, and Hematology Section 4.13: Clinical Pharmacology: Gastrointestinal & Hepatic Disorders Section 4.14: Therapeutic Decision-Making in Special Populations (Geriatrics, Pediatrics, Pregnancy, Lactation)

Section 2.14: Pharmaceutical Calculations: Osmolarity, Milliequivalents, and Alligations

Key Takeaways Explain This Topic AI

Osmolarity measures active particles per liter of solution and determines fluid toxicity and tonicity relative to blood (~285-300 mOsmol/L).

Milliequivalents (mEq) represent the chemical activity of electrolytes, calculated as mEq = (mg * Valence) / MW.

The Sodium Chloride Equivalent (E-value) represents the mass of NaCl that produces the same osmotic effect as 1 g of a drug.

Alligation alternate is a rapid grid method used to determine the proportion of two different strength components required to prepare a target intermediate strength.

Last updated: July 2026

Pharmaceutical Calculations: Osmolarity, Milliequivalents, and Alligations

Advanced pharmaceutical calculations are essential for compounding isotonic formulations, determining electrolyte balances in Total Parenteral Nutrition (TPN), and mixing bulk solutions of varying strengths. This section details the principles of osmolarity, milliequivalent chemical activity, sodium chloride equivalent ( E E E -value) tonicity adjustments, and alligation grid calculations.

Osmolarity versus Osmolality

Osmotic pressure dictates the movement of water across biological membranes. Injectable and ophthalmic formulations must be formulated to minimize tissue damage, pain, or hemolysis of red blood cells:

Osmolarity: The concentration of osmotically active particles per Liter of solution (expressed in mOsmol/L \text{mOsmol/L} mOsmol/L ).

Osmolality: The concentration of osmotically active particles per Kilogram of solvent (expressed in mOsmol/kg \text{mOsmol/kg} mOsmol/kg ).

In clinical practice, body fluids have an osmolality of approximately 285 to 300 mOsmol/kg 285\text{ to }300\text{ mOsmol/kg} 285 to 300 mOsmol/kg . Formulations that deviate significantly from this range are:

Hypotonic ( < 280 mOsmol/L <280\text{ mOsmol/L} < 280 mOsmol/L ): Cause water to enter cells, potentially leading to cell swelling and hemolysis.

Hypertonic ( > 310 mOsmol/L >310\text{ mOsmol/L} > 310 mOsmol/L ): Cause water to leave cells, leading to crenation. Hypertonic infusions must be administered through a central venous catheter rather than a peripheral line to prevent thrombophlebitis.

Osmolarity Calculation Equation mOsmol/L = Weight of solute (g/L) Molecular Weight (g/mol) ⋅ Dissociation Particles ( i ) ⋅ 1000 \text{mOsmol/L} = \frac{\text{Weight of solute (g/L)}}{\text{Molecular Weight (g/mol)}} \cdot \text{Dissociation Particles } (i) \cdot 1000 mOsmol/L = Molecular Weight (g/mol) Weight of solute (g/L) ​ ⋅ Dissociation Particles ( i ) ⋅ 1000

where i i i is the number of species formed upon dissociation (e.g., Dextrose i = 1 i = 1 i = 1 ; NaCl i = 2 \text{NaCl } i = 2 NaCl i = 2 ; CaCl 2 i = 3 \text{CaCl}_2\text{ } i = 3 CaCl 2 ​ i = 3 ).

Milliequivalents (mEq) Dosing

Milliequivalents express the chemical activity of electrolytes. It accounts for both the molar concentration and the electrical valence of the ions: mEq = Weight (mg) ⋅ Valence Molecular Weight \text{mEq} = \frac{\text{Weight (mg)} \cdot \text{Valence}}{\text{Molecular Weight}} mEq = Molecular Weight Weight (mg) ⋅ Valence ​ mEq = mmol ⋅ Valence \text{mEq} = \text{mmol} \cdot \text{Valence} mEq = mmol ⋅ Valence

Physiologically, electrolytes are measured in milliequivalents because it represents charge matching. For instance, in TPN formulation, balancing the positive charges of cations ( N a + Na^+ N a + , K + K^+ K + , M g 2 + Mg^{2+} M g 2 + , C a 2 + Ca^{2+} C a 2 + ) with the negative charges of anions ( C l − Cl^- C l − , acetate, phosphate) is essential to maintain electrical neutrality and prevent precipitation of salts.

Calcium Dosing: Gluconate versus Chloride

Clinical pharmacists must distinguish between Calcium Gluconate and Calcium Chloride :

Calcium Gluconate: Preferred for peripheral administration because it is less irritating to veins and carries a lower risk of tissue necrosis if extravasation occurs. A 1 g 1\text{ g} 1 g vial contains 93 mg 93\text{ mg} 93 mg ( 4.65 mEq 4.65\text{ mEq} 4.65 mEq ) of elemental calcium.

Calcium Chloride: More irritating and typically reserved for central line administration in emergency resuscitation. A 1 g 1\text{ g} 1 g vial contains 273 mg 273\text{ mg} 273 mg ( 13.6 mEq 13.6\text{ mEq} 13.6 mEq ) of elemental calcium (almost three times the amount of elemental calcium as gluconate).

Tonicity Adjustment and Sodium Chloride Equivalent ( E E E -value)

An isotonic solution contains osmotic activity equivalent to a 0.9 % w/v 0.9\%\text{ w/v} 0.9% w/v Sodium Chloride solution ( 0.9 g/100 mL 0.9\text{ g/100 mL} 0.9 g/100 mL ). The Sodium Chloride Equivalent ( E E E -value) of a drug is the mass of sodium chloride (in grams) that has the same osmotic effect as 1 gram 1\text{ gram} 1 gram of the drug. E-value ≈ 58.5 ⋅ i drug MW drug ⋅ 1.8 \text{E-value} \approx 58.5 \cdot \frac{i_{\text{drug}}}{\text{MW}_{\text{drug}} \cdot 1.8} E-value ≈ 58.5 ⋅ MW drug ​ ⋅ 1.8 i drug ​ ​

where 1.8 1.8 1.8 accounts for the dissociation of sodium chloride (which is 90 % 90\% 90% dissociated in solution, so i = 1.8 i = 1.8 i = 1.8 ).

Five-Step Method to Calculate Tonicity Adjustments:

Calculate the mass (in grams) of the drug in the formulation.

Multiply the mass of the drug by its E E E -value to determine the sodium chloride equivalent mass of the drug.

Calculate the total mass of sodium chloride needed to make the volume of the formulation isotonic in the absence of any drug ( Volume (mL) ⋅ 0.009 g/mL \text{Volume (mL)} \cdot 0.009\text{ g/mL} Volume (mL) ⋅ 0.009 g/mL ).

Subtract the drug's sodium chloride equivalent mass (Step 2) from the total sodium chloride required (Step 3). This represents the mass of sodium chloride to add.

If a tonicity agent other than sodium chloride (e.g., dextrose) is used, divide the mass of sodium chloride to add (Step 4) by the E E E -value of that agent.

The Alligation Alternate Method

Alligation alternate is a rapid grid method used to find the ratio of two starting strengths (high H H H and low L L L ) required to make an intermediate target strength ( T T T ):

  • Parts of High = ∣ T − L ∣ |T - L| ∣ T − L ∣ (placed adjacent to High)
  • Parts of Low = ∣ H − T ∣ |H - T| ∣ H − T ∣ (placed adjacent to Low)

Convert the parts into total volume or weight based on requirements.

  • Step-by-Step Worked Clinical Calculations
  • Example 1: Calculating Theoretical Osmolarity

Calculate the theoretical osmolarity of a 0.9 % w/v 0.9\%\text{ w/v} 0.9% w/v Sodium Chloride solution ( MW = 58.5 g/mol \text{MW} = 58.5\text{ g/mol} MW = 58.5 g/mol ). Assume sodium chloride dissociates completely into two particles ( i = 2 i = 2 i = 2 ).

Express the concentration in grams per Liter: 0.9 % w/v = 9.0 g/L 0.9\%\text{ w/v} = 9.0\text{ g/L} 0.9% w/v = 9.0 g/L

Apply the osmolarity equation: mOsmol/L = 9.0 g/L 58.5 g/mol ⋅ 2 ⋅ 1000 ≈ 308 mOsmol/L \text{mOsmol/L} = \frac{9.0\text{ g/L}}{58.5\text{ g/mol}} \cdot 2 \cdot 1000 \approx 308\text{ mOsmol/L} mOsmol/L = 58.5 g/mol 9.0 g/L ​ ⋅ 2 ⋅ 1000 ≈ 308 mOsmol/L

Example 2: Electrolyte Milliequivalent Calculation

How many milliequivalents of calcium are present in a 10 mL 10\text{ mL} 10 mL ampule of a 10 % w/v 10\%\text{ w/v} 10% w/v Calcium Gluconate injection ( MW = 430 g/mol \text{MW} = 430\text{ g/mol} MW = 430 g/mol , valence of calcium = 2 2 2 )?

Calculate the mass of calcium gluconate in the ampule: Mass = 10 % w/v ⋅ 10 mL = 1 g = 1000 mg \text{Mass} = 10\%\text{ w/v} \cdot 10\text{ mL} = 1\text{ g} = 1000\text{ mg} Mass = 10% w/v ⋅ 10 mL = 1 g = 1000 mg

Calculate milliequivalents: mEq = 1000 mg ⋅ 2 430 g/mol ≈ 4.65 mEq \text{mEq} = \frac{1000\text{ mg} \cdot 2}{430\text{ g/mol}} \approx 4.65\text{ mEq} mEq = 430 g/mol 1000 mg ⋅ 2 ​ ≈ 4.65 mEq

Example 3: Alligation Alternate Calculation

A pharmacist needs to prepare 500 mL 500\text{ mL} 500 mL of a 20 % 20\% 20% dextrose solution by mixing a 50 % 50\% 50% dextrose solution and sterile water ( 0 % 0\% 0% dextrose). Calculate the volume of each component required.

Set up alligation parts:

  • Parts of 50 % 50\% 50% dextrose = ∣ 20 − 0 ∣ = 20 parts |20 - 0| = 20\text{ parts} ∣20 − 0∣ = 20 parts
  • Parts of water = ∣ 50 − 20 ∣ = 30 parts |50 - 20| = 30\text{ parts} ∣50 − 20∣ = 30 parts
  • Total parts = 20 + 30 = 50 parts 20 + 30 = 50\text{ parts} 20 + 30 = 50 parts

Calculate the required volumes: Volume of 50% dextrose = 20 parts 50 total parts ⋅ 500 mL = 200 mL \text{Volume of 50\% dextrose} = \frac{20\text{ parts}}{50\text{ total parts}} \cdot 500\text{ mL} = 200\text{ mL} Volume of 50% dextrose = 50 total parts 20 parts ​ ⋅ 500 mL = 200 mL Volume of water = 30 parts 50 total parts ⋅ 500 mL = 300 mL \text{Volume of water} = \frac{30\text{ parts}}{50\text{ total parts}} \cdot 500\text{ mL} = 300\text{ mL} Volume of water = 50 total parts 30 parts ​ ⋅ 500 mL = 300 mL